# RECOMMEND Platform Trial

Study · id `cardio:ct-nct06526533` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06526533](<https://clinicaltrials.gov/study/NCT06526533>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06526533

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.

## Technical summary

Registry record NCT06526533. Randomized; no masking; primary purpose supportive care. Start 2026-03-23 (actual); primary completion 2028-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose supportive care
- Phase: Phase 3
- Enrolled: 600 participants (planned count; ClinicalTrials.gov record NCT06526533, source copy `cardio:ctgov-nct06526533-2026-05-13`, retrieved 2026-10-26)
- Started: 2026-03-23 (actual) (ClinicalTrials.gov record NCT06526533, source copy `cardio:ctgov-nct06526533-2026-05-13`, retrieved 2026-10-26)
- Primary completion: 2028-06 (anticipated) (ClinicalTrials.gov record NCT06526533, source copy `cardio:ctgov-nct06526533-2026-05-13`, retrieved 2026-10-26)
- Completion: 2029-06 (anticipated) (ClinicalTrials.gov record NCT06526533, source copy `cardio:ctgov-nct06526533-2026-05-13`, retrieved 2026-10-26)
- Countries: Australia (ClinicalTrials.gov record NCT06526533, source copy `cardio:ctgov-nct06526533-2026-05-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06526533-2026-05-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: RECOMMEND Platform Trial
- Acronym: RECOMMEND
- Condition: Extracorporeal Membrane Oxygenation Complication
- Condition: ARDS (Acute Respiratory Distress Syndrome)
- Condition: Intensive Care Medicine
- Condition: Cardiac Arrest (CA)
- Condition: Critical Illness
- Intervention (Other): Liberal RBC Transfusion
- Intervention (Other): Restrictive RBC Transfusion
- Lead sponsor: Australian and New Zealand Intensive Care Research Centre
- Lead sponsor class: OTHER
- Collaborator: Monash University
- Collaborator class: OTHER
- Collaborator: Berry Consultants
- Collaborator class: OTHER
- Collaborator: Research Path
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as a collaborator: Monash University (`cardio:org-monash-university`)
- Registry lists this organization as a collaborator: Berry Consultants (`cardio:org-berry-consultants`)

## Provenance

Content hash: 17dfd96b4e68e414c7dac2e57044b1482fcfef937180e048328af3b9b5e20268
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
